Pyridoxic acid (PA), also known as 4-pyridoxic acid, is a primary catabolic product of vitamin B6 (pyridoxine) metabolism and is excreted in the urine.
It reflects recent dietary intake and varies based on factors like gender and riboflavin deficiency.
Formed by enzymes such as aldehyde oxidase I and microbial enzymes, pyridoxic acid can be further broken down by gut microflora.
It's a crucial marker for vitamin B6 status, especially when assessing deficiencies or the effectiveness of supplementation programs.
In certain conditions like hypophosphatasia, where alkaline phosphatase activity is low, pyridoxal-5’-phosphate (PLP) levels are high while PA levels remain normal, indicating a disruption in vitamin B6 metabolism.
Pyridoxic acid, also known as 4-pyridoxic acid, is a catabolic product of vitamin B6 (pyridoxine) metabolism.
Pyridoxic acid is a 2-methylpyridine derivative.
It is the primary catabolic product of vitamin B6 and is excreted in the urine. Pyridoxic acid reflects immediate or very recent dietary intake. [3.]
Urinary levels of 4-pyridoxic acid are lower in females than males and are further reduced in individuals with riboflavin deficiency. It is formed by the action of aldehyde oxidase I and microbial enzymes, specifically pyridoxal 4-dehydrogenase, an NAD-dependent aldehyde dehydrogenase. [2., 12.]
Gut microflora can further break it down via 4-pyridoxic acid dehydrogenase, which catalyzes its oxidation to 3-hydroxy-2-methylpyridine-4,5-dicarboxylate using NAD as a cofactor. [2.]
Vitamin B6, primarily in its active form pyridoxal 5'-phosphate (PLP), is crucial for numerous enzymatic reactions in the body, including amino acid metabolism.
Alkaline phosphatase (ALP) is an enzyme that dephosphorylates PLP to pyridoxal (PL), which can then be further metabolized to pyridoxic acid (PA) for excretion.
In conditions like hypophosphatasia, where ALP activity is deficient, PLP accumulates in the blood, while PA levels remain relatively normal, highlighting the role of ALP in vitamin B6 metabolism.
Pyridoxic acid is assessed as a marker of vitamin B6 deficiency.
Pyridoxic acid levels in urine correlate with plasma pyridoxal phosphate (PLP) and red blood cell (RBC) PLP levels, which are the active forms of vitamin B6. This correlation makes pyridoxic acid a reliable marker for assessing vitamin B6 status. [9.]
When tested in blood, it is often tested alongside PLP (the active form of vitamin B6) for a more complete assessment of vitamin B6 status.
Vitamin B6 is a group of six compounds: pyridoxal, pyridoxol, pyridoxamine, and their 5'-phosphate esters. Pyridoxal 5-phosphate (PLP) is the biologically active form and serves as a cofactor in many enzymatic reactions.
Eukaryotes cannot synthesize vitamin B6 and must obtain it from their diet.
Pyridoxal 5′-phosphate (PLP), the most clinically significant form, is commonly measured in plasma and acts as a coenzyme for over 100 enzymes involved in amino acid, neurotransmitter, nucleic acid, heme, and lipid metabolism. It also plays a role in energy homeostasis.
Low plasma PLP levels are inversely associated with several chronic and acute diseases, including rheumatoid arthritis, cardiovascular disease, and cancer. This deficiency can occur without dietary insufficiency, possibly due to its mobilization to inflammation sites or increased catabolism during inflammation. [1.]
PLP is crucial for heme biosynthesis and B6 deficiency can lead to anemia and other inherited metabolic disorders. [1.]
Low PLP levels are linked with an increased risk of colorectal cancer, with a 49% decrease in risk for every 100-pmol/mL increase in blood PLP levels. [1.]
Various genetic conditions, malabsorption issues, and certain medications can lead to B6 deficiency.
Evaluating vitamin B6 status is crucial for diagnosing deficiencies, particularly in individuals with progressive nerve compression disorders like carpal and tarsal tunnel syndromes.
Deficiency in vitamin B6 can contribute to conditions such as burning mouth syndrome and exacerbate nerve compression disorders.
Symptoms of deficiency include skin scaling, severe gingivitis, irritability, weakness, depression, dizziness, peripheral neuropathy, and seizures.
In children, it may cause diarrhea, anemia, and seizures.
Elevated PLP with normal pyridoxic acid levels are seen in hypophosphatasia (HPP), a genetic disorder characterized by low serum alkaline phosphatase activity and high plasma PLP levels, due to impaired dephosphorylation by tissue nonspecific isoenzyme of alkaline phosphatase (TNSALP).
Despite high PLP levels, HPP patients generally do not exhibit B6-related symptoms.
Monitoring vitamin B6 status is also important for assessing the success of supplementation programs.
Pyridoxic acid is typically measured in urine samples, as it is primarily excreted through the kidneys. However, pyridoxic acid may also be tested in the blood, often alongside PLP, the active form of vitamin B6.
Blood samples require a venipuncture, while urine samples may be collected from home.
It is important to consult with the ordering provider regarding specific sample collection instructions. Generally, fasting and avoiding multivitamin supplements are required prior to sample collection.
Optimal levels of pyridoxic acid are reported as < 111.9
nmol/mg Creatinine. [10.]
Elevated levels of pyridoxic acid may indicate excessive supplementation, renal insufficiency, or certain metabolic disorders. [6.]
One large study of over 15,000 participants found that higher 4-pyridoxic acid levels were linearly associated with increased all-cause and cancer mortality risk. [11.]
Low levels of pyridoxic acid in urine can indicate a deficiency in vitamin B6. This may be due to inadequate intake, or issues with absorption.
Low pyridoxic acid levels can be seen in chronic conditions that affect vitamin B6 metabolism, such as chronic alcoholism and certain genetic disorders. [9.]
Pyridoxic acid levels can also be affected by riboflavin (vitamin B2) deficiency, as riboflavin is a cofactor for the enzyme that converts pyridoxal to pyridoxic acid. [9.]
Increased vitamin B6 catabolism to 4-PA, reflected by a higher 4-PA/pyridoxine ratio, is associated with higher cardiovascular risk in patients with type 2 diabetes.
This ratio is a strong marker for assessing cardiovascular risk, suggesting that enhanced vitamin B6 catabolism may be linked to vascular damage. [7.]
Patients with hypophosphatasia, an inborn error characterized by deficient activity of tissue nonspecific alkaline phosphatase (AP), exhibit markedly increased circulating levels of pyridoxal-5'-phosphate (PLP).
One study demonstrated that the mean PLP concentration in patients with hypophosphatasia was significantly higher (1174 nM) compared to control subjects (57±26 nM). [13.]
Despite these elevated PLP levels, the urinary excretion of 4-pyridoxic acid (PA), a degradation product of PLP, remained unremarkable in affected children consuming normal dietary amounts of vitamin B6. [13.]
The study indicates that tissue nonspecific AP plays a crucial role in vitamin B6 metabolism by regulating extracellular PLP levels but not intracellular levels.
Consequently, measuring only circulating PLP concentrations may not accurately assess vitamin B6 nutrition in conditions with altered AP activity, such as hypophosphatasia.
This suggests that hypophosphatasia results in elevated PLP due to a failure in PLP hydrolysis by tissue nonspecific AP, while PA levels remain normal, highlighting the enzyme's role as an ectoenzyme.
Click here to compare testing options and order testing for pyridoxic acid and related markers of vitamin B6 status.
[1.] 004655: Vitamin B6, Plasma | Labcorp. www.labcorp.com. https://www.labcorp.com/tests/004655/vitamin-b-sub-6-sub-plasma
[2.] 4-Pyridoxic Acid. Human Metabolome Database. https://hmdb.ca/metabolites/HMDB0000017
[3.] Ayling RM. Clinical biochemistry of nutrition. Clinical Biochemistry: Metabolic and Clinical Aspects. Published online 2014:180-199. doi:https://doi.org/10.1016/b978-0-7020-5140-1.00010-9
[4.] B6PRO - Overview: Vitamin B6 Profile (Pyridoxal 5-Phosphate and Pyridoxic Acid), Plasma. @mayocliniclabs. Published 2018. Accessed July 22, 2024. https://www.mayocliniclabs.com/test-catalog/overview/42360#Clinical-and-Interpretive
[5.] Brown MJ, Ameer MA, Daley SF, et al. Vitamin B6 Deficiency. [Updated 2023 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470579/
[6.] Coburn SP, Reynolds RD, Mahuren JD, Schaltenbrand WE, Wang Y, Ericson KL, Whyte MP, Zubovic YM, Ziegler PJ, Costill DL, Fink WJ, Pearson DR, Pauly TA, Thampy KG, Wortsman J. Elevated plasma 4-pyridoxic acid in renal insufficiency. Am J Clin Nutr. 2002 Jan;75(1):57-64. doi: 10.1093/ajcn/75.1.57. PMID: 11756060.
[7.] Obeid R, Geisel J, Nix WA. 4-Pyridoxic Acid/Pyridoxine Ratio in Patients with Type 2 Diabetes is Related to Global Cardiovascular Risk Scores. Diagnostics (Basel). 2019 Mar 6;9(1):28. doi: 10.3390/diagnostics9010028. PMID: 30845778; PMCID: PMC6468858.
[8.] Pfeiffer CM, Schleicher RL, Caldwell KL. Biochemical Indices. Elsevier eBooks. Published online January 1, 2013:156-174. doi:https://doi.org/10.1016/b978-0-12-375083-9.00198-7
[9.] Pyridoxine Deficiency Workup: Laboratory Studies, Other Tests. emedicine.medscape.com. Accessed July 22, 2024. https://emedicine.medscape.com/article/124947-workup?form=fpf
[10.] Rupa Health. Organic Acids Profile Sample Report.pdf. Google Docs. https://drive.google.com/file/d/1vsMjcLWAcWYwyisdAVOsn_IwIvJrpmfV/view
[11.] Schorgg P, Karavasiloglou N, Beyer A, et al. Increased vitamin B6 turnover is associated with greater mortality risk in the general US population: A prospective biomarker study. Clinical nutrition. 2022;41(6):1343-1356. doi:https://doi.org/10.1016/j.clnu.2022.04.023
[12.] Stanulović M, V. Jeremić, V. Leskovac, Chaykin S. New Pathway of Conversion of Pyridoxal to 4-Pyridoxic Acid. Enzyme. 1976;21(4):357-369. doi:https://doi.org/10.1159/000458879
[13.] Whyte MP, Mahuren JD, Vrabel LA, Coburn SP. Markedly increased circulating pyridoxal-5’-phosphate levels in hypophosphatasia. Alkaline phosphatase acts in vitamin B6 metabolism. Journal of Clinical Investigation. 1985;76(2):752-756. Accessed July 22, 2024. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC423894